IN THIS issue of the ARCHIVES, McDougle and colleagues1 report on another interesting, placebo-controlled trial of psychotropic medication in the treatment of autism. Following their study of fluvoxamine,2 McDougle and colleagues demonstrate the efficacy for risperidone in the treatment of severe behavioral problems frequently, but not invariably, found in persons with autistic disorder. These are important and valuable findings. So, with all this good news, what is the irony?
Leventhal BL, Cook EH, Lord C. The Irony of Autism. Arch Gen Psychiatry. 1998;55(7):643-644. doi:10.1001/archpsyc.55.7.643